Breast-specific gamma imaging developer Dilon Diagnostics has signed a three-year sales agreement with mammography information systems developer PenRad Technologies.
Under the terms of the pact, Dilon's portfolio now will include the PenRad mammography information system (MIS) and also Volpara, a quantitative breast density assessment tool designed to convert a qualitative breast x-ray image into quantitative data.Dilon inks sales pact with PenRad
Latest in Breast
USPSTF finalizes breast cancer screening recommendations
April 30, 2024
Large language models underperform in breast imaging
April 30, 2024